JW Bioscience Introduces Biochemical Analysis Equipment

Contract Signed with Global Diagnostic Analysis Equipment Specialist 'Jeol'

[Asia Economy Reporter Cho Hyun-ui] JW Bioscience announced on the 13th that it has signed an exclusive supply contract for biochemical analyzers with Jeol, a global diagnostic analysis equipment specialist.

Under this contract, JW Bioscience will exclusively supply all models of Jeol's biochemical analyzers domestically and leverage its diagnostic reagent research and development (R&D) capabilities to develop its own reagents.

Jeol, established in 1946, is a specialist company in diagnostic analysis equipment, developing and selling electron optical devices, measuring instruments, and semiconductor equipment. It holds the number one market share in the biochemical field in Japan.

The biochemical analyzers introduced by JW Bioscience include the JCA-BM6010, JCA-BM6070, and JCA-BM8000 series, which chemically analyze various specimens such as blood and urine to diagnose the presence of diseases and assess treatment effectiveness.

A JW Bioscience official stated, "We plan to intensify the development of biochemical diagnostic reagents and increase our market share in the domestic diagnostic market, which has been mostly dominated by foreign products such as those from Japan."

This content was produced with the assistance of AI translation services.